393
Views
0
CrossRef citations to date
0
Altmetric
REVIEW

Teclistamab for Multiple Myeloma: Clinical Insights and Practical Considerations for a First-in-Class Bispecific Antibody

ORCID Icon &
Pages 741-751 | Received 20 Apr 2023, Accepted 05 Jul 2023, Published online: 21 Jul 2023